{"id":"https://openalex.org/W2009966734","doi":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","title":"Remission and Relapse in the Outpatient Care of Schizophrenia: Three-year Results From the Schizophrenia Outpatient Health Outcomes Study","display_name":"Remission and Relapse in the Outpatient Care of Schizophrenia: Three-year Results From the Schizophrenia Outpatient Health Outcomes Study","alternate_titles":[],"publication_year":2006,"publication_date":"2006-11-18","ids":{"openalex":"https://openalex.org/W2009966734","doi":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","mag":"2009966734","pmid":"https://pubmed.ncbi.nlm.nih.gov/17110813"},"language":"en","primary_location":{"id":"doi:10.1097/01.jcp.0000246215.49271.b8","doi":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2009966734"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108145160","display_name":"Josep Maria Haro","orcid":"https://orcid.org/0000-0002-3984-277X","observed_orcids":["https://orcid.org/0000-0002-3984-277X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Josep Maria Haro","raw_affiliation_strings":["Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain. jmharo@comb.es","Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain. jmharo@comb.es","institution_ids":[]},{"raw_affiliation_string":"Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107876782","display_name":"Diego Novick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Diego Novick","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, Surrey, UK","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, Surrey, UK","institution_ids":["https://openalex.org/I4210095227"]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101744608","display_name":"David L. Suarez","orcid":"https://orcid.org/0000-0003-4582-6116","observed_orcids":["https://orcid.org/0000-0003-4582-6116"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"David Suarez","raw_affiliation_strings":["Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain","UNIVERSITY OF BARCELONA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sant Joan de Deu-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi de Llobregat, Barcelona, Spain","institution_ids":[]},{"raw_affiliation_string":"UNIVERSITY OF BARCELONA","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002758767","display_name":"Jordi Alonso","orcid":"https://orcid.org/0000-0001-8627-9636","observed_orcids":["https://orcid.org/0000-0001-8627-9636"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111631","display_name":"H\u00f4pital Fernand-Widal","ror":"https://ror.org/01zkyzz15","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210111631"]},{"id":"https://openalex.org/I4210124576","display_name":"Institut Municipal d'Assist\u00e8ncia Sanit\u00e0ria","ror":"https://ror.org/02trgd202","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210124576","https://openalex.org/I4210133106"]},{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"Jordi Alonso","raw_affiliation_strings":["Institut Municipal d'Investigaci\u00f3 M\u00e8dicia (IMIM-IMAS), Barcelona, Spain and \u00a7UMR INSERM-CNRS, H\u00f4pital Fernand Widal, AP-HP, Paris, France","Municipal Institute for Medical Research Hospital del Mar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Municipal d'Investigaci\u00f3 M\u00e8dicia (IMIM-IMAS), Barcelona, Spain and \u00a7UMR INSERM-CNRS, H\u00f4pital Fernand Widal, AP-HP, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210111631","https://openalex.org/I4210124576"]},{"raw_affiliation_string":"Municipal Institute for Medical Research Hospital del Mar","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109213794","display_name":"Jean Pierre Lepine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Pierre L\u00e9pine","raw_affiliation_strings":["Assistance publique \u2013 H\u00f4pitaux de Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assistance publique \u2013 H\u00f4pitaux de Paris","institution_ids":["https://openalex.org/I4210097159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110896346","display_name":"Mark Ratcliffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Mark Ratcliffe","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, Surrey, UK","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, Surrey, UK","institution_ids":["https://openalex.org/I4210095227"]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5101744608","https://openalex.org/A5108145160"],"corresponding_institution_ids":["https://openalex.org/I71999127"],"apc_list":null,"apc_paid":null,"fwci":4.8722,"has_fulltext":false,"cited_by_count":148,"citation_normalized_percentile":{"value":0.94810139,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"26","issue":"6","first_page":"571","last_page":"578"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.9869999885559082},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.9950000047683716},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.7570000290870667},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9179999828338623},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8259999752044678},{"id":"https://openalex.org/keywords/social-functioning","display_name":"social functioning","score":0.7570000290870667},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.9860000014305115},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.8510000109672546},{"id":"https://openalex.org/keywords/hostility","display_name":"hostility","score":0.7409999966621399},{"id":"https://openalex.org/keywords/risk-factors-for-recurrence","display_name":"recurrence risk factors","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.6941789388656616},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6700105667114258},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5877314805984497},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4964502453804016},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.4815852642059326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4642055630683899},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.42685067653656006},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4111618995666504},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.41023173928260803},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3964528441429138},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33274370431900024}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077582","descriptor_name":"Amisulpride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.jcp.0000246215.49271.b8","doi":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000246215.49271.b8","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:17110813","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17110813","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/366a1146-ad1a-4bd0-bfab-c730fee092e1","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/366a1146-ad1a-4bd0-bfab-c730fee092e1","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W154345872","https://openalex.org/W1573622717","https://openalex.org/W1898894110","https://openalex.org/W1974856103","https://openalex.org/W1979519168","https://openalex.org/W1980938357","https://openalex.org/W1981405738","https://openalex.org/W1988245592","https://openalex.org/W1992254481","https://openalex.org/W1992413851","https://openalex.org/W1998373426","https://openalex.org/W2002583102","https://openalex.org/W2033428561","https://openalex.org/W2048187664","https://openalex.org/W2096824069","https://openalex.org/W2099123602","https://openalex.org/W2127888526","https://openalex.org/W2128423141","https://openalex.org/W2135689380","https://openalex.org/W2139773071","https://openalex.org/W2143162969","https://openalex.org/W2154849243","https://openalex.org/W2158826778","https://openalex.org/W2159155203","https://openalex.org/W2163337176","https://openalex.org/W2166581792","https://openalex.org/W2167725527","https://openalex.org/W2297765042","https://openalex.org/W2316180061","https://openalex.org/W2993399942","https://openalex.org/W4323285018"],"related_works":["https://openalex.org/W2154326961","https://openalex.org/W2059164276","https://openalex.org/W1999881425","https://openalex.org/W2040373715","https://openalex.org/W2095998841","https://openalex.org/W2466098810","https://openalex.org/W2615948593","https://openalex.org/W1634899948","https://openalex.org/W1996867392"],"abstract_inverted_index":{"Remission":[0],"and":[1,14,16,19,90,155,173,178,251,265],"relapse":[2,126,141,216,260],"are":[3],"clinical":[4,20],"outcomes":[5],"of":[6,30,41,84,94,113,131,140,150,165,170,176,186,193,204,211,215,223,240,249,259,275],"increasing":[7],"interest":[8],"in":[9,26,47,128],"schizophrenia.":[10],"We":[11],"analyzed":[12,61],"remission":[13,67,114,205,225,242],"relapse,":[15,166],"the":[17,27,33,48,58,69,132,138,145,174,190,194,202,208,247,276],"sociodemographic":[18],"factors":[21,97,159],"associated":[22,99,108,160,181,235,254],"with":[23,43,100,104,109,116,137,161,182,232,236,255,262],"these":[24],"outcomes,":[25],"usual":[28],"care":[29],"schizophrenia":[31,44],"using":[32],"3-year,":[34,70],"follow-up":[35,71,146],"data":[36],"from":[37],"a":[38,81,91,110,162,183,237,256],"large":[39],"cohort":[40],"outpatients":[42],"taking":[45],"part":[46],"prospective,":[49],"observational,":[50,277],"European":[51],"Schizophrenia":[52,195],"Outpatient":[53,196],"Health":[54,197],"Outcomes":[55,198],"study.":[56],"Of":[57],"6516":[59],"patients":[60,133],"for":[62],"remission,":[63,136],"4206":[64],"(64.6%)":[65],"achieved":[66,135],"during":[68,144],"period.":[72,147],"Logistic":[73],"regression":[74],"analysis":[75],"revealed":[76],"that":[77,125,201,230],"being":[78],"female,":[79],"having":[80,152],"good":[82,168],"level":[83,169],"social":[85,171],"functioning":[86,172],"at":[87],"study":[88,199,279],"entry,":[89],"shorter":[92],"duration":[93,149],"illness":[95],"were":[96,158,180],"significantly":[98],"achieving":[101,224,241],"remission.":[102],"Treatment":[103],"olanzapine":[105,177,233,250],"was":[106],"also":[107],"higher":[111,163],"frequency":[112],"compared":[115,261],"other":[117,244],"antipsychotic":[118],"agents.":[119],"A":[120],"Kaplan-Meier":[121],"survival":[122],"curve":[123],"estimated":[124],"occurred":[127],"approximately":[129],"25%":[130],"who":[134],"risk":[139,164,185,214,258],"remaining":[142],"constant":[143],"Shorter":[148],"illness,":[151],"hostile":[153],"behaviors,":[154],"substance":[156],"abuse":[157],"whereas":[167],"use":[175,248],"clozapine":[179,252],"lower":[184,257],"relapse.":[187],"In":[188],"conclusion,":[189],"3-year":[191],"results":[192,269],"indicate":[200],"likelihood":[203],"decreases":[206],"over":[207],"longitudinal":[209],"course":[210],"schizophrenia,":[212],"but":[213],"is":[217,234,253],"maintained":[218],"even":[219],"after":[220],"3":[221],"years":[222],"severity":[226],"levels.":[227],"Results":[228],"suggest":[229],"treatment":[231],"better":[238],"chance":[239],"than":[243],"antipsychotics.":[245,267],"Moreover,":[246],"risperidone,":[263],"quetiapine,":[264],"typical":[266],"The":[268],"should":[270],"be":[271],"interpreted":[272],"conservatively":[273],"because":[274],"nonrandomized":[278],"design.":[280]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2009966734","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
